Removing C. Difficile From GI Pathogen Panels May Reduce Unnecessary Treatment, Research Suggests

Healio (12/6, Stulpin) reported, “Researchers found that removing Clostridioides difficile from gastrointestinal pathogen panels reduced unnecessary treatment without causing delays in diagnosis.” One researcher said, “Clinical decision support and diagnostic stewardship of GI pathogen panel results can optimize preferred testing. ... Results are best when stakeholders are included in the process.” The findings were published in Infection Control & Hospital Epidemiology.